Centro Ricerche Cliniche di Verona Srl,
Verona, (Vr), 37100, Italy
NCT Number: NCT03234452
A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of inflammation and intestinal barrier function and gastrointestinal symptoms in healthy volunteers with self-reported anxiety.
Looking for future studies?
Notify Me20 year–35 year
All sexes
Interventional
Not applicable
Verona, (Vr), 37100, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y, module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.
Exclusion criteria
Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics within 30 days prior to the screening visit, and use of drugs, food or herbal supplements for digestive symptoms.
2 vials with dosing cap (10 mL) a day per os
2 vials with dosing cap (10 mL) a day per os
Time frame: 45 days
Verify that Natural Killer activities concentration is significantly higher in the experimental Group compared to the placebo group
Time frame: 45 days
Time frame: 45 days
Time frame: 45 days
Time frame: 45 days
Montefarmaco OTC SpA
Industry
Evaluation of the Beneficial Effects of a Probiotic Product (Lactoflorene Plus) in Healthy Adult Subjects in Particular Psychological Stress Conditions.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05936541
Disbiosis, Dysbiosis
Latina, Italy
View Trial DetailsNCT07530575
Body Weight, Cardiovascular Diseases
Buenos Aires, Buenos Aires City, Argentina
View Trial DetailsNCT06944288
Disbiosis, Dysbiosis
View Trial DetailsNCT02530216
Abdominal Pain, Constipation
Los Angeles, California, United States
View Trial Details